Plus Therapeutics, Inc.
PSTV
$0.59
$0.00-0.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.90% | 275.20% | -433.61% | -2.44% | 10.72% |
| Total Depreciation and Amortization | -61.31% | -54.71% | -5.81% | 58.46% | 5.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | 163.49% | -558.89% | 6,934.27% | -16.28% | -480.72% |
| Change in Net Operating Assets | 907.05% | -272.79% | 10.18% | 50.57% | -142.39% |
| Cash from Operations | 30.76% | -404.17% | -36.76% | 35.62% | -53.40% |
| Capital Expenditure | -92.86% | 91.36% | 92.50% | 73.81% | -40.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26,380.00% | -24.29% | 1,189.81% | -- | -- |
| Cash from Investing | 14,511.11% | -21.83% | 1,077.47% | 252.38% | 10.00% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -1,640.05% | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -58.74% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10,220.00% | -388.89% | -- | -- | 122.50% |
| Cash from Financing | -- | -59.84% | 1,698.58% | 100.00% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 399.70% | -479.61% | 273.20% | 53.22% | -3,423.42% |